RCUS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Arcus Biosciences Inc

Watchlist Manager

Watchlist

Price: 24.69 USD -2.14% Market Closed

Market Cap: $3.1B

	Arcus Biosciences Inc NYSE:RCUS	US
	Kearny Financial Corp NASDAQ:KRNY	US
	Cambridge Cognition Holdings PLC F:1M7	UK
	Ubiquiti Inc NYSE:UI	US
M	MEP Corporation PCL SET:MEB	TH
	Atossa Therapeutics Inc NASDAQ:ATOS	US
	Kbc Groep NV OTC:KBCSY	BE
K	Keurig Dr Pepper Inc SWB:DP5	US

Profitability Summary

Arcus Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-415%

Negative 3Y Average Operating Margin

-195%

Declining Operating Margin

-270% > -415%

Negative Net Margin

-393%

Negative 3Y Average Net Margin

-179%

Declining Net Margin

-245% > -393%

Negative Free Cash Flow Margin

-406%

Negative 3Y Average Free Cash Flow Margin

-185%

Declining Free Cash Flow Margin

-256% > -406%

Negative ROE

-91%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-171%

Declining ROIC

-93% > -301%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.